Intertek Acquires QTI Laboratory

07 Jun 2007

London UK - Intertek Group plc (Intertek), a leading international provider of quality and safety services to a wide range of industries, has acquired Quantitative Technologies Inc (QTI).

QTI is a leading contract analytical research and development laboratory that has been serving the pharmaceutical, medical device and drug delivery industry in North America for over 15 years, specialising in the pre-market launch stages of the drug and product development life cycle. QTI is located in Whitehouse, New Jersey with approximately 60 staff and counts major global pharmaceutical companies among its clients. The laboratory is highly regarded for technical expertise, rigorous compliance programs, and outstanding customer service – it is a current Good Manufacturing Practice (cGMP) facility in good standing with the US Food and Drug Administration (FDA).

The acquisition further advances Intertek’s strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry through the provision of state of the art analytical services.

About Intertek:

Intertek Group PLC is a leading international provider of quality and safety services to a wide range of global and local industries. Partnership with Intertek brings increased value to customers’ products and processes, ultimately supporting their success in the global market place. Intertek has the experience, expertise, resources and global reach to support its customers through their network of more than 930 laboratories and offices and over 18,000 people in 109 countries around the world.

The range of current services from Intertek Pharmaceutical Services, Whitehouse, NJ can be found at https://www.intertek.com/pharmaceutical/analysis/whitehouse-nj/